2 sources • 3 verified points
US FDA Approves PASCAL Precision System for Tricuspid Valve Disease
Edwards Lifesciences announced the US Food and Drug Administration's approval of the PASCAL Precision system. The approval opens a new treatment pathway for patients with tricuspid valve disease, according to the company.
AI-written summary of 2 sources; every verified point is backed by a verbatim quote. How Iyan works
- The FDA approved the system for repairing the tricuspid heart valve.
«وافقت إدارة الغذاء والدواء الأميركية على نظام PASCAL Precision من شركة Edwards Lifesciences لإصلاح صمام القلب ثلاثي الشرفات»
Cardiovascular Business - The company announced the approval in a statement published on October 21, 2026.
«أعلنت شركة Edwards Lifesciences اعتماد نظام PASCAL Precision من إدارة الغذاء والدواء الأميركية»
Business Wire - The sources did not include further details about the nature of the system or the results of its trials.
«ولم يتضمن الوصف تفاصيل أخرى عن النظام»
Business Wire • Cardiovascular Business
Iyan — See it for yourself. What changed in your world today, why it matters, and how we know.
How it works • Privacy • Terms